BELITE BIO, INC Operating Income Loss

• BELITE BIO, INC showed a decrease of -110.5% in Operating Income Loss from 2024 to 2025.
• This data is from BELITE BIO, INC's annual report (Form 10-K), filed with the SEC on March 31, 2026.
• XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 6 years of available data (2020 to 2025), BELITE BIO, INC's Operating Income Loss has declined by 1,366.3%.
• Historical annual values: Fiscal year 2025: -$84.21 million | Fiscal year 2024: -$40.00 million | Fiscal year 2023: -$31.67 million | Fiscal year 2022: -$12.82 million | Fiscal year 2021: -$9.80 million | Fiscal year 2020: -$5.74 million.
• Data sourced from SEC EDGAR public filings as of June 21, 2026.

Last verified: June 21, 2026